Dr.ย Darylย Tan
MBBS, MRCP (UK)
Consultant Haematologist
corporate_fareMount Elizabeth Novena Hospital, Singapore
Daryl Tan
MBBS, MRCP (UK)
Dr. Daryl Tan is a Singapore-based haematologist who focuses on lymphoma, multiple myeloma and other blood cancers. He is a consultant at the Clinic for Lymphoma, Myeloma and Blood Disorders at Mount Elizabeth Novena Hospital, and previously served as clinical lead for the lymphoma and myeloma services at Singapore General Hospital.
He graduated in medicine from the National University of Singapore in 1997 and obtained Membership of the Royal College of Physicians (UK) in 2002, completing his internal medicine and haematology training at Singapore General Hospital. In 2007 he was awarded a national Human Manpower Development Plan fellowship to pursue postdoctoral training and clinical research in lymphoma at Stanford University in the United States. On returning to Singapore he led the lymphoma and myeloma services at Singapore General Hospital and ran several clinical trials of novel approaches for these diseases before moving into specialist private practice. He was elected to the International Myeloma Working Group in 2014, sits on the advisory panel of the International Myeloma Foundation's Asia Myeloma Network, and has authored more than 130 peer-reviewed publications alongside over 80 invited international lectures.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Tan, subject to availability and case acceptance.
Why Consider Dr. Daryl Tan?
Dr. Tan is a sub-specialised blood-cancer physician with deep focus on lymphoma and multiple myeloma and a strong record in clinical research.
Areas of Specialization
Focused care for lymphoma, multiple myeloma and other blood cancers
Lymphoma
Hodgkin and non-Hodgkin lymphoma, from indolent to aggressive subtypes.
- arrow_rightDiffuse large B-cell and follicular lymphoma management
- arrow_rightNK/T-cell lymphoma, including immunotherapy-based approaches
- arrow_rightTailored treatment for indolent versus aggressive disease
- arrow_rightChemotherapy and immunochemotherapy protocols
- arrow_rightManagement of relapsed and refractory disease
Multiple Myeloma & Plasma Cell Disorders
Novel-agent and immunotherapy-based treatment for myeloma and related conditions.
- arrow_rightProteasome inhibitor and immunomodulatory drug regimens
- arrow_rightAnti-CD38 monoclonal antibody therapy (e.g. daratumumab)
- arrow_rightManagement of relapsed and refractory myeloma
- arrow_rightAssessment and treatment of related plasma cell dyscrasias
Leukaemia & Other Blood Cancers
Chronic lymphocytic leukaemia and other haematological malignancies.
- arrow_rightChemo-free targeted treatment approaches where suitable
- arrow_rightRisk-based monitoring and treatment timing
- arrow_rightAcute and chronic leukaemias
- arrow_rightMyelodysplastic syndromes and myeloproliferative neoplasms
Procedures Performed
Clinical services and treatment approaches in haematology
Systemic Therapy for Blood Cancers
Medical OncologyTreatment planning and administration of systemic therapy for lymphoma, myeloma and leukaemia.
Diagnosis & Disease Work-Up
DiagnosisComprehensive diagnostic evaluation and staging for blood cancers.
Relapsed & Refractory Disease
Complex DiseaseManagement of difficult, relapsed or treatment-resistant blood cancers.
Second Opinion Consultations
Second OpinionIndependent expert review of a blood-cancer diagnosis and treatment plan.
Research & Publications
Clinical research and peer-reviewed contributions in lymphoma and myeloma
A more detailed publication list may be available on request via CancerFax.
Education & Training
Dr. Tan trained in medicine and haematology in Singapore and the United Kingdom, with postdoctoral lymphoma research at Stanford University.
Clinical Experience
Over two decades in haematology, spanning Singapore General Hospital and dedicated specialist practice in Singapore.
Languages & International
Dr. Daryl Tan consults in the following language.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Daryl Tan
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Daryl Tan's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Daryl Tan's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Daryl Tan before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Daryl Tan's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Daryl Tan's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Daryl Tan's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Daryl Tan
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Daryl Tan, subject to availability and case acceptance.
Dr. Tan focuses on blood cancers, particularly lymphoma (Hodgkin and non-Hodgkin), multiple myeloma and chronic lymphocytic leukaemia. He also manages other leukaemias, myelodysplastic syndromes and myeloproliferative neoplasms.
He practises at the Clinic for Lymphoma, Myeloma and Blood Disorders at Mount Elizabeth Novena Hospital in Singapore. He was previously the clinical lead for the lymphoma and myeloma services at Singapore General Hospital.
Yes. A second-opinion request can be submitted through CancerFax with your pathology and bone marrow reports, imaging, and treatment history. Dr. Tan can review the case and provide a written haematology opinion, with the consultation format depending on availability.
He offers chemotherapy and immunochemotherapy for lymphoma, novel-agent regimens for multiple myeloma, immunotherapy for selected lymphomas, and chemo-free targeted approaches for CLL where suitable. For patients with relapsed or refractory disease, he can assess access to novel therapeutics and clinical-trial options.
Yes. He has authored more than 130 peer-reviewed publications, led clinical trials in lymphoma and myeloma, and is an elected member of the International Myeloma Working Group and an advisor to the Asia Myeloma Network.
Connect with Daryl Tan Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.